Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Cash & Current Investments: 2009-2024

Historic Cash & Current Investments for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to $348.5 million.

  • Pediatrix Medical's Cash & Current Investments rose 11006.89% to $463.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $463.1 million, marking a year-over-year increase of 11006.89%. This contributed to the annual value of $348.5 million for FY2024, which is 9607.3% up from last year.
  • According to the latest figures from FY2024, Pediatrix Medical's Cash & Current Investments is $348.5 million, which was up 9607.3% from $177.7 million recorded in FY2023.
  • Pediatrix Medical's Cash & Current Investments' 5-year high stood at $1.2 billion during FY2020, with a 5-year trough of $103.1 million in FY2022.
  • In the last 5 years, Pediatrix Medical's Cash & Current Investments had a median value of $348.5 million in 2024 and averaged $469.0 million.
  • In the last 5 years, Pediatrix Medical's Cash & Current Investments soared by 57371.04% in 2020 and then tumbled by 7884.18% in 2022.
  • Pediatrix Medical's Cash & Current Investments (Annual) stood at $1.2 billion in 2020, then plummeted by 60.36% to $487.1 million in 2021, then tumbled by 78.84% to $103.1 million in 2022, then surged by 72.46% to $177.7 million in 2023, then surged by 96.07% to $348.5 million in 2024.
  • Its Cash & Current Investments was $348.5 million in FY2024, compared to $177.7 million in FY2023 and $103.1 million in FY2022.